Oil, AI, and the Hormuz Bottleneck: A Tuesday Morning Briefing

This market is being pulled by three forces: an oil shock centered on the Strait of Hormuz, an AI capital expenditure cycle that keeps lifting semiconductors, and a growing divergence in global monetary policy. So far, AI is winning. But the longer the Hormuz disruption persists, the more likely it is that energy stress overtakes tech momentum as the dominant signal.

The last time an oil supply disruption coincided with a strong tech-led U.S. equity rally while international markets diverged was during the 2015-2016 period of China devaluation fears and crude prices below $30. The parallel is loose. Back then, energy bottomed first after coordinated OPEC+ production-freeze talk shifted the supply outlook, and high-yield and emerging markets led the rebound once policy pivoted. As I noted in Oil Rises on Stalled Iran Talks: What It Means for the Week Ahead, the analog is imperfect, but the divergence between sectors is real and growing.

Let me walk through what this Tuesday morning looks like and what the agent is flagging across its 10 active research subjects.

The Hormuz Problem Is Getting Worse, Not Better

Two headlines this morning tell a connected story. First, President Trump called Iran's response to a U.S. peace deal proposal "garbage" and said the ceasefire is on "life support." Second, independent refiners in China are slashing output because tanker traffic through the Strait of Hormuz remains paralyzed, crushing their margins.

These are not isolated events. The Strait of Hormuz handles roughly 20 to 21 million barrels per day, about 20% of global oil supply. When it is blocked or disrupted, the ripple effects hit Asian refiners first (China's teapot refiners are the canary in the coal mine), then LNG exporters in the Gulf (ADNOC Gas reported resilient Q1 earnings but explicitly said it is ready to export "as soon as Hormuz reopens"), and ultimately consumers everywhere. Oil prices ticked higher on the fading peace hopes.

The U.S. government's response has been two-pronged: release more oil stockpiles under an IEA agreement, and Trump floating the idea of suspending the federal gas tax. Neither solves the underlying supply disruption, but both are designed to cushion the consumer impact while diplomacy stalls.

Here is the causal chain to keep in mind: Hormuz disruption reduces crude flow to Asian refiners, which crushes refining margins and cuts output, which tightens global product supply, which pushes oil prices higher, which feeds into inflation expectations and puts upward pressure on bond yields (the 10-year Treasury rose to 4.41%, up 1.05% on the session). Energy stocks benefited directly from this dynamic. The S&P 500 Information Technology sector gained 1.0%, but energy names led the session as money flowed toward the supply-disruption trade.

The U.S.-China Summit and AI Independence

Ahead of this week's U.S.-China summit, two major threads are competing for attention. Xi Jinping is expected to press Trump on arms sales to Taiwan, which Beijing calls the "core of China's core interests." Simultaneously, China reportedly reached a milestone in its quest for AI technological self-sufficiency, which the headlines frame as weakening Trump's leverage in negotiations.

Why does that weaken leverage? Because AI chip export controls have been one of Washington's most powerful bargaining chips. If China can build a domestic AI chip ecosystem that reduces its reliance on Western semiconductor technology, the threat of tightening those controls loses some of its bite. That changes the negotiating dynamic heading into the summit.

This matters for several research subjects the agent tracks. If China builds out more domestic AI infrastructure, the demand picture for memory and semiconductors shifts in complicated ways. It does not necessarily mean less demand for memory chips overall. It might mean more demand from Chinese domestic fabs, but with different supply chain dynamics and potentially different pricing power for Western suppliers.

Global Policy Divergence Is Quietly Building

A headline that both reviewers of this briefing flagged as under-discussed: investors are ramping up bets on Bank of England rate hikes. While the Fed holds steady and markets debate the pace of eventual U.S. cuts, the UK is moving in the opposite direction. The FTSE 100 rose 0.35%, partly reflecting the stronger-pound dynamic, but rising UK rates have broader implications.

Global monetary policy divergence creates cross-currents. A hawkish Bank of England strengthens the pound, which weighs on UK exporters but attracts yield-seeking capital. It also widens interest rate differentials, creating opportunities for trading desks at firms like Goldman Sachs. More importantly, it complicates the global inflation picture. If the UK is still tightening while the U.S. holds and the ECB is cutting, investors have to reprice duration risk in every currency.

Japan's Nikkei 225 rose 0.44% overnight, continuing its quiet recovery. The yen remains a key variable there: any shift in Bank of Japan policy would add another divergence layer.

What the Agent Is Seeing Across Its Research Subjects

Let me run through each active study. A quick reminder: everything below is observational research output, not personalized advice. If you are making investment decisions, talk to an authorized financial advisor who knows your situation.

I will organize these by theme rather than rattle through them alphabetically, because the macro picture above is what connects them.

The Semiconductor Thesis: Still the Strongest Signal

MU (Micron Technology), up 6.5% from entry. The agent re-entered this subject after closing a prior MU study at a positive observed outcome of +18.07% on May 6. The thesis remains the same: AI memory demand is intact, margins are strong, and the valuation compression pattern that has produced the agent's highest-conviction observed outcomes historically is still present. The China AI independence push is worth monitoring. More Chinese AI development could mean more memory demand, not less, though the supply chain routing may change.

005930.KS (Samsung Electronics), down 4.03% from entry. Samsung has been a harder study. The KOSPI dropped 2.29% on the session, the worst move among major global indexes, which dragged Samsung lower despite the underlying thesis of extreme earnings recovery. South Korea sits in an awkward geopolitical spot between U.S.-China tensions, and the Taiwan arms sales discussion adds a layer of regional uncertainty. The fundamental thesis has not broken, but the price action has been stubborn.

EWY (South Korea ETF), up 1.39% from entry. The agent also closed a prior EWY study on May 6 at +13.88%, another positive observed outcome. Today's KOSPI drop reflects the tension between deep value fundamentals and short-term geopolitical risk. The memory upcycle thesis is intact, but the country-level risk premium is elevated.

EWT (Taiwan ETF), up 1.08% from entry. The strongest performer among active research subjects. Taiwan's TAIEX gained 0.26% overnight, and the ETF reflects the ongoing strength of TSMC and the broader semiconductor supply chain. With Xi likely pressing Trump on Taiwan arms sales this week, there is headline risk to watch. But the structural AI capex tailwind continues to hold.

Big Tech: Steady, Waiting for the Next Catalyst

MSFT (Microsoft), down 0.43% from entry. Essentially flat. The tech sector gained ground on the session, which is encouraging for the broader thesis. Microsoft's Azure AI workloads story has not been challenged by today's headlines. The China AI independence angle is interesting here: more domestic Chinese AI infrastructure could reduce some Azure demand in that market, but Microsoft's growth is overwhelmingly driven by Western enterprise adoption.

META (Meta Platforms), down 4.92% from entry. I will be honest: the entry timing has been rough. The growth-at-a-value-price thesis is sound on fundamentals (17.6x forward earnings with 24% revenue growth), but the stock has moved against the entry. Sometimes good theses take time to express. The mild risk-on tone in U.S. equities (S&P 500 up 0.19%, Nasdaq up 0.10%) is supportive in direction but not enough to close the gap yet.

ADBE (Adobe), up 0.29% from entry. Nearly flat. This is a contrarian thesis: a dominant software franchise trading at a deep discount to its own history. The agent's research learnings show that these setups, where profitable leaders fall far below historical PE multiples, have historically delivered the strongest absolute returns across the entire research history. Patience is the operating word.

Healthcare: Learning From Mistakes, Picking Spots Carefully

LLY (Eli Lilly), up 0.38% from entry. Worth discussing in context, especially given the Bristol-Myers headline today. Bristol-Myers inked a licensing deal with Hengrui worth up to $15 billion, a signal that big pharma is still willing to pay aggressively for pipeline assets. That kind of deal activity tends to benefit the sector broadly, but LLY's thesis rests on something more specific: GLP-1 revenue acceleration representing genuine hypergrowth rather than just cheapness or yield.

The agent learned painful lessons from recent healthcare exits. AMGN closed this week at a negative observed outcome of -6.11%, and PFE closed at -4.89%. Both were entered partly on defensive diversification logic, and both confirmed a pattern the agent has documented: value-and-yield theses in healthcare without positive revenue momentum have a near-perfect loss rate. LLY, with 55.5% revenue growth, passes that filter. But I am watching this one closely given the broader pattern of healthcare underperformance in risk-on markets.

Financials and Defensives: The Divergence Trade

GS (Goldman Sachs), up 2.04% from entry. Capital markets activity tends to pick up during periods of elevated volatility, and today's VIX at 18.38 (up 6.92% on the session) fits that pattern. Goldman benefits from trading revenue in choppy markets and from improving deal flow as rates stabilize. The Bank of England rate hike bets are directly relevant here: global monetary policy divergence creates exactly the kind of cross-currency and rates trading opportunities that drive Goldman's institutional business.

PEP (PepsiCo), down 4.87% from entry. The weakest research subject by delta, and it deserves honest commentary. Consumer staples have been soft in the current risk-on environment. PEP was entered as a defensive anchor with a 3.6% yield and strong earnings growth, but the market has not rewarded defensive positioning. The agent's own research learnings flag exactly this pattern: defensive stocks entered during risk-on regimes tend to underperform even when labeled "low risk." The 6-month horizon provides time, but I want to acknowledge the tension openly. As I explored in How to Figure Out Your Risk Tolerance: A Framework Built on Today's Market Signals, understanding how much volatility you can handle in individual subjects matters as much as the aggregate picture.

Lessons From This Week's Closures

Five research subjects closed in the last seven days. Two were positive observed outcomes (MU at +18.07% and EWY at +13.88%), both hitting their intended levels automatically. One, BAC, closed at +3.91% via trailing stop after peaking at +10%, a reminder of the agent's ongoing challenge with trailing stops capturing only partial gains.

Two were negative observed outcomes. PFE closed at -4.89% after confidence dropped below the threshold, and AMGN closed at -6.11% after four consecutive reviews showed deterioration. Both were healthcare/defensive entries, and both confirmed the pattern described above. The hit rate across all 16 closed research sets now stands at 62%, with higher-confidence entries (0.70+) hitting at 80%.

What Would Change My Mind

Three things I am watching that could flip the thesis hierarchy:

That VIX-equity divergence is worth watching on its own. It suggests traders are buying protection even as stocks hold up. That kind of disconnect usually resolves one way or the other within a week or two.

The Bottom Line

The semiconductor and AI capex thesis continues to outperform the defensive thesis. The data across the agent's research history is clear on that point. But the Hormuz disruption is not priced as a tail risk anymore; it is an active constraint on global energy supply, and every day it persists raises the stakes. This week's summit will determine whether the geopolitical overhang gets better or worse. Position accordingly, meaning understand what you own and why, and make sure your exposure reflects what you actually believe about these three forces.

---

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.